Medios logo

Medios

Stock
Stock
ISIN: DE000A1MMCC8
Ticker: ILM1
DE000A1MMCC8
ILM1

Price

Price

CHART BY

Frequently asked questions

The market capitalization of Medios is $303.94M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
The Price-to-Earnings (P/E) ratio (TTM) for Medios is 23.50. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
Medios's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.528. EPS indicates the company's profitability on a per-share basis.
Currently, 5 analysts cover Medios's stock, with a consensus target price of $22.06. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, Medios reported a revenue of $2.51B.
Medios's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $93.39M. EBITDA measures the company's overall financial performance.
Medios has a free cash flow of $26.42M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
Medios employs approximately 982 people. It operates in the Health Care sector, specifically within the Medical Distributors industry.
The free float of Medios is 15.02M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$303.94M
EPS (TTM) 
$0.528
Free Float 
15.02M
P/E ratio (TTM) 
23.50
Revenue (TTM) 
$2.51B
EBITDA (TTM) 
$93.39M
Free Cashflow (TTM) 
$26.42M

Pricing

1D span
$12.25$12.58
52W span
$12.33$20.61

Analyst Ratings

The price target is $22.06 and the stock is covered by 5 analysts.

Buy

4

Hold

1

Sell

0

Information

Medios AG is a holding company, which engages in the provision of pharmaceutical drugs. It operates through the following segments: Pharmaceutical Supply, Patient-Specific Therapies, and Services. The Pharmaceutical Supply segment focuses on specialty pharmaceuticals for chronic and/or rare diseases. The Patient-Specific Therapies segment involves in the manufacturing of medications. The Services segment consists of the Groups other activities. The company was founded in 1980 and is headquartered in Berlin, Germany.

Employees
982
Industries
Medical Distributors
Sector
Health Care

Identifier

ISIN
DE000A1MMCC8
Primary Ticker
ILM1

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation